<div id="content" class="col-md-12" style="">
<div data-drupal-messages-fallback="" class="hidden"/><div id="block-medsites-page-title" class="widget block">
<h1><span property="schema:name">ACS</span>
</h1>
</div>
<div id="block-medsites-content" class="widget block">
<article data-history-node-id="1036" role="article" about="/commodorecompendium/acs" typeof="schema:WebPage">
<div>
<div property="schema:text" class="field field--name-body field--type-text-with-summary field--label-hidden field__item"><div style="border-bottom:solid windowtext 1.0pt; border-top:double windowtext 1.5pt; border-left:none; border-right:none; padding:1.0pt 0in 1.0pt 0in">
<p style="border:none; padding:0in"><span style="font-size:11pt"><span style="line-height:107%"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino">Acute Coronary Syndrome - Nick King</span></span></span></b></span></span></span></p>
</div>
<p><span style="font-size:11pt"><span style="line-height:107%"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino">Background</span></span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">Completely</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> or partially occluding thrombus on a disrupted atherothrombotic coronary plaque leading to myocardial ischemia/infarction</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">STEMI</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">: Elevated troponin &amp; elevation in ST segment or new LBBB with symptoms</span></span></span></span></span>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><u><span style="font-size:12.0pt"><span style="font-family:Palatino">&gt;</span></span></u> <span style="font-size:12.0pt"><span style="font-family:Palatino">0.1 mV in at least 2 contiguous leads </span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Exception</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">, in V2-V3: </span></span></span></span></span>
<ul>
<li style="list-style-type:none">
<ul style="list-style-type:disc">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">&gt; 0.2 </span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">mV</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> in men older than 40 y/o  </span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">&gt; 0.25 </span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">in</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> men younger than 40 y/o</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">&gt; 0.15 </span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">mV</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> in women </span></span></span></span></span> </li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">NSTEMI</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">: Evidence of myocardial necrosis (elevated troponin) w/o ST segment elevation</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">Unstable</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> Angina: Angina without evidence of myocardial necrosis (normal troponin) </span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">Other</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> causes of myocardial injury: coronary spasm, embolism, imbalance of oxygen demand and supply 2/2 fever, tachycardia, hypo-/hypertension</span></span></span></span></span></li>
</ul>
<p> </p>
<p><span style="font-size:11pt"><span style="line-height:107%"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino">Presentation</span></span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">Angina</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> or <span style="color:#232323">Anginal</span> equivalents: </span></span></span></span></span> 

	<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Exertional</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> dyspnea, nausea, weakness; and epigastric pain in women and diabetics</span></span></span></span></span> </li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">Change</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> in patients’ baseline angina, especially onset at rest</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">Physical</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> Exam: sinus tachycardia, diaphoresis</span></span></span></span></span></li>
</ul>
<p> </p>
<p><span style="font-size:11pt"><span style="line-height:107%"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino">Evaluation</span></span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">EKG</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">:</span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Compare</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> to prior EKG and assess for </span></span></span></span></span>
<ul style="list-style-type:disc">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">New ST elevations or ST depressions</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">T </span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">wave</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> inversions: less specific but more concerning if deep (&gt; 0.3mV)</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Biphasic T waves and T wave inversions in leads V2 &amp; V3 (Wellen’s sign [LAD])</span></span></span></span></span></li>
</ul>
</li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">Cardiac</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> biomarkers: troponin I is most sensitive for myocardial injury</span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">ACC</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">/AHA guidelines recommend <b>both</b> EKG and trop q6 hours </span></span></span></span></span>
<ul style="list-style-type:disc">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Consider this if high suspicion for primary ACS, despite normal initial markers</span></span></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">If </span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">negative</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> x2, stop checking</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Can be negative initially; Troponin takes ~2-3 hours to become detectable with ischemia</span></span></span></span></span></li>
</ul>
</li>
</ul>
<p> </p>
<p><span style="font-size:11pt"><span style="line-height:107%"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino">Management</span></span></span></span></span></span></p>
<p><span style="font-size:11pt"><span style="line-height:107%"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino">STEMI:  </span></span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">STAT page Cardiology on call via Synergy (whether in VA or Vanderbilt)</span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">ASAP: aspirin 325mg, heparin drip (high nomogram, with bolus) </span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">Hold P2Y12 until discussed with Cards fellow, patient may instead be taken directly to cath lab and loaded with anti-platelet agent there (prasugrel or ticagrelor)</span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">Additional</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> therapy during hospital stay: </span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">High Intensity statin therapy:  Early initiation of statin in ACS reduces risk of short- and long-term coronary events</span></span></span></span></span></li>
</ul>
</li>
</ul>
<p style="margin-left:50px"> </p>
<p><span style="font-size:11pt"><span style="line-height:107%"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino">NSTEMI:</span></span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">Medical</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> management with left-heart catheterization within 48 hours of presentation. </span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">General</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">: bedrest, telemetry, repeat EKG with recurrent chest pain, NPO at midnight</span></span></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">Anti</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">-thrombotic therapy: </span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Antiplatelet</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> agents: </span></span></span></span></span>
<ul style="list-style-type:disc">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">ASA 325 mg loading dose then 81 mg daily after</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">P2Y12 receptor blocker (can give Plavix (600 mg x1 -&gt; 75 mg daily)</span></span></span></span></span></li>
</ul>
</li>
</ul>
</li>
<li style="list-style-type:none">
<ul style="list-style-type:circle">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Anti-</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">coagulants</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">: Unfractionated heparin drip</span></span></span></span></span>
<ul style="list-style-type:disc">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Type</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> this in Epic and select “nursing managed” protocol for “ACS” </span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">VA it can be found under the “Orders” tab along the left-hand column. </span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">No adjustment needed for renal function</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Enoxaparin</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> (LMHW) can be used but requires preserved renal function and most interventionalists prefer heparin prior to LHC</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Anticoagulation</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> can be stopped after catheterization if patient has no obstructive CAD, undergoes PCI, or after 48 hours (pure medical management)</span></span></span></span></span></li>
</ul>
</li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">Additional</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> therapy: Maximal statin therapy (atorvastatin 80 QD or rosuvastatin 40mg) </span></span></span></span></span></li>
</ul>
<p style="margin-left:25px"> </p>
<p><span style="font-size:11pt"><span style="line-height:107%"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino">Post ACS Care: </span></span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">DAPT</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">: Aspirin 81 mg daily and P2Y12 agent (clopidogrel, ticagrelor, prasugrel)</span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">P2Y12 </span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">agent</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> determined by cardiology</span></span></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">Beta</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> blocker in all patients within 24 hours </span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Metoprolol</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">, carvedilol &amp; bisoprolol have proven mortality benefit with reduced EF</span></span></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">TTE to assess EF</span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">ACEi/ARB if anterior STEMI, LVEF &lt;40%, or CHF</span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">Aldo Antagonists if LVEF&lt;40% with HF symptoms or DM</span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">Lipid panel and A1c</span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">High intensity statin, consider ezetimibe if LDL &gt; 70</span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">Lifestyle Modification: Weight loss, exercise, smoking cessation, in DM goal A1c &lt; 7%</span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">Outpatient Cardiology follow up </span></span></span></span></span></span></li>
</ul>
<p> </p>
<p><span style="font-size:11pt"><span style="line-height:107%"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino">Additional Information:</span></span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">Initiate</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> treatment if there is true concern for ACS, medications can always be discontinued  </span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">TIMI</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> score: &gt;2 correlates with </span></span><span style="font-size:12.0pt"><span style="font-family:&quot;Times New Roman&quot;,serif">↑</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> mortality, indicating a need for aggressive treatment</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">Ticagrelor</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> and prasugrel are superior for prevention of MI and stroke but have an increased bleeding risk, and will delay surgery (CABG) so defer to Cardiology to initiate</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:#232323">Complications</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">:</span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">VT/VF, sinus bradycardia, third-degree heart block, new VSD, LV perforation, acute mitral regurgitation, pericarditis and cardiogenic shock; More common with STEMI</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">STEMI</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> is usually managed in CCU post-catherization</span></span></span></span></span></li>
</ul>
</li>
</ul>
</div>
</div>
</article>
</div>
</div>